医学
血压
观察研究
冲程(发动机)
药物治疗
不利影响
临床试验
抗高血压药
内科学
老年人
心脏病学
重症监护医学
老年学
机械工程
工程类
作者
Jamie Falk,Liesbeth Froentjes,Jessica Kirkwood,Balraj S Heran,Michael R. Kolber,G. Michael Allan,Christina Korownyk,Scott Garrison
出处
期刊:The Cochrane library
[Elsevier]
日期:2024-12-17
卷期号:2024 (12): CD011575-CD011575
被引量:6
标识
DOI:10.1002/14651858.cd011575.pub3
摘要
When comparing a higher BP target, in the range of < 150 to 160/95 to 105 mmHg, to a lower BP target of 140/90 or lower, over two to four years of follow-up, there is high-certainty evidence that the lower BP target reduces stroke, and moderate-certainty evidence that the lower BP target likely reduces serious cardiovascular events. The effect on all-cause mortality is unclear (low-certainty evidence), and the lower BP target likely does not increase withdrawals due to adverse effects (moderate-certainty evidence). Although additional research is warranted in those who are 80 years of age and older, and those who are frail (in whom risks and benefits may differ), conventional BP targets may be appropriate for the majority of older adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI